ProKidney Investor Relations Material
Latest events
Q3 2023
ProKidney
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from ProKidney Corp
Access all reports
ProKidney LP is an biotech company that develops cellular and gene therapies treatments, mainly targeting the chronic kidney disease (CKD). ProKidney LP was founded in 2015.
Key slides for ProKidney Corp
Q3 2023
ProKidney Corp
Q3 2023
ProKidney Corp
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States